​

Decoy Therapeutics Ownership | Who Owns Decoy Therapeutics?


OverviewFinancialsChart

Decoy Therapeutics Ownership Summary


Decoy Therapeutics is owned by 0.81% institutional investors, 10.44% insiders, and 88.75% retail investors. Commonwealth equity services is the largest institutional shareholder, holding 6.02% of DCOY shares. Fidelity Extended Market Index is the top mutual fund, with 1.29% of its assets in Decoy Therapeutics shares.

DCOY Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDecoy Therapeutics0.81%10.44%88.75%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Commonwealth equity services32.00K6.02%$63.04K
Ubs group4.53K0.85%$8.91K
Vanguard capital management4.03K0.76%$7.95K
Jpmorgan chase80.000.01%$170.00
Advisory services network---
Morgan stanley---
Caitong asset management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Commonwealth equity services32.00K0.00%$63.04K
Jpmorgan chase80.00-$170.00
Ubs group4.53K-$8.91K
Advisory services network---
Morgan stanley---
Caitong asset management---
Vanguard capital management4.03K-$7.95K

Top Buyers

HolderShares% AssetsChange
Commonwealth equity services32.00K0.00%32.00K
Ubs group4.53K-4.50K
Jpmorgan chase80.00-80.00
Vanguard capital management4.03K--
Morgan stanley---1.00

Top Sellers

HolderShares% AssetsChange
Advisory services network---41.00
Caitong asset management---2.00
Morgan stanley---1.00
Vanguard capital management4.03K--
Jpmorgan chase80.00-80.00

New Positions

HolderShares% AssetsChangeValue
Commonwealth equity services32.00K0.00%32.00K$63.04K
Jpmorgan chase80.00-80.00$170.00

Sold Out

HolderChange
Morgan stanley-1.00
Caitong asset management-2.00
Advisory services network-41.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20264-4,317168.30%-886.94%2-50.00%2-
Mar 31, 20264-1,609---4---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index7.61K1.29%-
Vanguard Institutional Extnd Mkt Idx Tr4.03K0.76%-
Spartan Extended Market Index Pool F1.28K0.24%-
Fidelity Series Total Market Index477.000.08%-
Spartan Total Market Index Pool G169.000.03%-
Spartan Total Market Index Pool A1169.000.03%-
Horizon Kinetics Medical ETF20.000.00%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 30, 2025HANISH ARNOLD C-Sell$7.68
Dec 30, 2025HANISH ARNOLD C-Sell$9.60
Nov 20, 2025HANISH ARNOLD C-Buy$3.74K
Nov 20, 2025Rosenblum Mark J Exec VP Finance, CFOBuy$16.00K
Jun 07, 2022Burleson Tess Buy$4.99K

Insider Transactions Trends


DateBuySell
2026 Q3--
2025 Q422
2024 Q2--
2024 Q1--
2023 Q1--

DCOY Ownership FAQ


Who Owns Decoy Therapeutics?

Decoy Therapeutics shareholders are primarily institutional investors at 0.81%, followed by 10.44% insiders and 88.75% retail investors. The average institutional ownership in Decoy Therapeutics's industry, Biotech Stocks , is 385.89%, which Decoy Therapeutics falls below.

Who owns the most shares of Decoy Therapeutics?

Decoy Therapeutics’s largest shareholders are Commonwealth equity services (32K shares, 6.02%), Ubs group (4.52K shares, 0.85%), and Vanguard capital management (4.03K shares, 0.76%). Together, they hold 7.62% of Decoy Therapeutics’s total shares outstanding.

Does Blackrock own Decoy Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Decoy Therapeutics.

Who is Decoy Therapeutics’s biggest shareholder by percentage of total assets invested?

Commonwealth equity services is Decoy Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 32K Decoy Therapeutics shares, valued at 63.04K$.

Who is the top mutual fund holder of Decoy Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Decoy Therapeutics shares, with 1.29% of its total shares outstanding invested in 7.61K Decoy Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools